Has the pharmaceutical industry been the worst affected by the country-wide imposed flight ban?
Yes- according to Howard Archer, an Analyst at IHS Global Insight. Archer stated that the pharmaceutical industry has been the worst affected as ‘many of its products moved around by air and needing to be delivered quickly.’
Not only this, but the pharmaceutical industry is notoriously heavily reliant on importing raw materials needed to manufacture their drugs. Understandably, any setback in the supply of these materials can lead to delays in production.
Pharmaceutical products such as vaccines, which have a short shelf life, could prove useless when they eventually reach customers.
However, it seems the big name pharmaceutical companies have remained relatively unaffected, with share prices recovering since the disruption began last Thursday. GlaxoSmithKline’s shares rose 0.35% to 1,283.5p, while AstraZeneca rose 0.7% or 21p to 2,964p.
Looking for a new job in the pharmaceutical industry? Click here to search our current pharmaceutical job vacancies.